Latest Headlines
-
Faculty honored at 2023 Argus Awards ceremony
On Friday, Nov. 17, 2023, students from Heersink School of Medicine gathered to celebrate faculty, courses, and course directors at the annual Argus Awards Ceremony.
-
12 honored for excellence in teaching
Twelve faculty have been selected to receive the President’s Award for Excellence in Teaching, which honors those who have demonstrated exceptional accomplishments in teaching. The 2023 honorees represent each school, the College of Arts and Sciences, the Honors College, and[…]
-
Bjornsti begins her term as president of FASEB
FASEB is the largest coalition of biological and biomedical research associations in the United States and advocates for basic biomedical research.
-
UAB Medicine leadership programs celebrate more than 100 participants
In the last several years, UAB Medicine and Heersink School of Medicine have worked to bring leadership development to faculty and staff through the UAB Medicine Institute for Leadership and Momentum in Medicine programs.
-
Rhythmic eating pattern preserves fruit fly muscle function under obese conditions
Mechanistic findings in this study may pave the way for future time-restricted feeding studies in muscle, providing a natural and affordable form of alternative therapy for managing pathologies related to metabolism and obesity.
-
Faculty honored at 2022 Argus Awards ceremony
Medical students honored their outstanding mentors, professors, courses, and course directors at the annual Argus Awards Ceremony on Friday, Jan. 6.
-
Wilborn named interim chair of the Department of Pharmacology and Toxicology
Teresa Wilborn, Pharm.D., Ph.D., will serve as interim chair of the Department of Pharmacology and Toxicology, effective Jan. 1.
-
New Research Faculty Introduction
The UAB Heersink School of Medicine Office of Research introduces new faculty for Spring and Summer 2022. Please join Heersink School of Medicine and the Office of Research in welcoming these new faculty.
-
Mary-Ann Bjornsti takes new leadership role at FASEB as president-elect
FASEB is the largest coalition of biological and biomedical research associations in the United States.
-
Novel preclinical drug could have potential to combat depression, brain injury and cognitive disorders
The drug inhibits the kinase Cdk5, found in mature neurons. Cdk5 has long been implicated in neuropsychiatric and neurodegenerative conditions, but previous inhibitors have largely failed to reach the brain through the blood-brain barrier.